News

The deal extends reach of Claris’s products in Europe, North America and Australia. Pfizer will undertake the commercialisation of the products that have gone off-patent in the western

The drug is designed to block production of a protein that carries LDL cholesterol in the blood. It met its primary goal in a study of 51 patients

The regulatory submission has been filed in the UK and Spain under the European decentralised procedure. The UK regulatory authority, the Medicines and Healthcare products Regulatory Agency (MHRA),

The drug is being manufactured jointly by Bayer HealthCare and Onyx Pharmaceuticals. The approval was based on a positive data from the international, Phase III double-blind, placebo-controlled Sorafenib

The collaboration draws synergy from Lilly’s insulin expertise and Medtronic’s diabetes technologies. The alliance is expected to enhance awareness level of the people and help them benefit from

The deal with Novartis may exceed $500 million, including the initial acquisition payment plus potential additional regulatory and sales milestone payments. The agreement also includes right to an

Vernakalant is an investigational candidate used for the treatment of atrial fibrillation. As per the terms of the agreement, effectiveness of the agreement triggers an initial payment of

CLL is caused when too many abnormal white blood cells are developed in blood and bone marrow. The abnormal cells surpass the number of normal white blood cells,

Enzyme replacement therapy for the treatment of HPP is the company’s lead program. The FDA has granted fast track designation in part because HPP is an untreated, serious